PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Kordbacheh, T. [1 ,2 ]
Chan, C. [1 ]
Bossons, A. [2 ,3 ]
Franks, K. [4 ]
McDonald, F. [5 ]
Forster, M. [6 ]
Mendes, R. [7 ]
Quezada, S. [8 ]
Dovedi, S. [9 ]
Ralph, C. [10 ]
Popat, S. [11 ]
Harrington, K. [12 ,13 ]
Melcher, A. [14 ]
Popple, A. [9 ]
Illidge, T. [9 ]
Faivre-Finn, C. [1 ,2 ]
机构：
[1] Christie NHS Fdn Trust, Clin Oncol, Manchester, Lancs, England
[2] Univ Manchester, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Clin Trials Unit, Manchester, Lancs, England
[4] St James Univ Hosp, Leeds Canc Ctr, Clin Oncol, Leeds, W Yorkshire, England
[5] Royal Marsden NHS Fdn Trust, Clin Oncol, London, England
[6] UCL, Oncol, London, England
[7] Univ Coll London Hosp, Clin Oncol, London, England
[8] UCL Canc Inst, Immune Regulat & Tumour Immunotherapy, London, England
[9] Canc Res UK Manchester Inst, Targeted Therapy, Manchester, Lancs, England
[10] Univ Leeds, Leeds Immunotherapy Team, Leeds, W Yorkshire, England
[11] Royal Marsden Hosp, Lung Oncol Unit, London, England
[12] Royal Marsden NHS Fdn Trust, Clin Oncol, Targeted Therapy, Manchester, Lancs, England
[13] Inst Canc Res, Manchester, Lancs, England
[14] Inst Canc Res, Translat Immunol, Manchester, Lancs, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
164
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 50 条
  • [1] Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
    Moreno, V.
    Gil-Martin, M.
    Johnson, M.
    Aljumaily, R.
    Lopez Criado, P.
    Northfelt, D. W.
    Crittenden, M.
    Jabbour, S.
    Rosen, L.
    Garrido Lopez, P.
    Hervas Moron, A.
    Rietschel, P.
    Mohan, K. K.
    Li, J.
    Stankevich, E.
    Rowlands, T.
    Feng, M.
    Lowy, I.
    Fury, M. G.
    ANNALS OF ONCOLOGY, 2018, 29 : 414 - 414
  • [2] Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
    Moreno, V.
    Gil-Martin, M.
    Johnson, M. L.
    Aljumaily, R.
    Criado, P. Lopez
    Northfelt, D. W.
    Crittenden, M.
    Jabbour, S.
    Rosen, L.
    Garrido, P.
    Moron, A. Hervas
    Rietschel, P.
    Mohan, K. K.
    Li, J.
    Stankevich, E.
    Feng, M.
    Lowy, I.
    Fury, M. G.
    ANNALS OF ONCOLOGY, 2018, 29 : 26 - 26
  • [3] Tislelizumab: an investigational anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer (NSCLC)
    Liu, Si-Yang
    Wu, Yi-Long
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (12) : 1355 - 1363
  • [4] A phase I study of bortezomib, paclitaxel, carboplatin (CBDCA), and radiotherapy (RT) for locally advanced non-small cell lung cancer (NSCLC)
    Schild, S. E.
    Molina, J. R.
    Dy, G. K.
    Rowland, K. M.
    Sarkaria, J. N.
    Thomas, S. P.
    Northfelt, D. W.
    Kugler, J. W.
    Foster, N. R.
    Adjei, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] A phase I study of binimetinib, a MEK inhibitor, in combination with pembrolizumab in patients with advanced non-small cell lung cancer (NSCLC)
    Theriau, Christopher F.
    Feng, Jamie
    Eng, Lawson
    Shepherd, Frances A.
    DeCarolis, Mary
    Glenns, Vivian
    Kulkarni, Swati
    VanderMeer, Rachel
    Zurawska-Fortin, Urszula
    Hao, Desiree
    Le, Lisa
    Wozniczka, Isabel
    Al-Kindy, Aida
    Xie, Danny
    Zhang, Tong
    Subramanian, Vasanth
    Stockley, Tracy
    Bradbury, Penelope A.
    Liu, Geoffrey
    Leighl, Natasha B.
    CANCER RESEARCH, 2023, 83 (08)
  • [6] Anti-PD-1 antibody monotherapy or anti-PD-1 antibody combination with chemotherapy treated non-small cell lung cancer (NSCLC) patients with EGFR mutation: A retrospective analysis.
    Yu, Shaorong
    Hu, Ran
    Shi, Meiqi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Anti-PD-1 With or Without Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer
    Teng, F.
    Wang, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E455 - E456
  • [8] A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC).
    Hoffman, PC
    Mauer, AM
    Haraf, DC
    Lester, EP
    Szeto, LL
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 648S - 648S
  • [9] Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer
    Fournel, P.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S94 - S100
  • [10] Complete response with anti-PD-L1 antibody following progression on anti-PD-1 antibody in advanced non-small cell lung cancer
    Singh, Navdeep
    Seetharamu, Nagashree
    BMJ CASE REPORTS, 2020, 13 (08)
12345